Institute of General Practice, Rostock University Medical Centre, Doberaner Str. 142, 18057, Rostock, Germany.
Institute of Medical Biometry and Epidemiology, Medical Centre Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.
BMC Fam Pract. 2021 May 15;22(1):93. doi: 10.1186/s12875-021-01436-6.
We investigate whether an educational intervention of GPs increases patient-centeredness and perceived shared decision making in the treatment of patients with poorly controlled type 2 diabetes mellitus?
We performed a cluster-randomized controlled trial in German primary care. Patients with type 2 diabetes mellitus defined as HbA1c levels ≥ 8.0% (64 mmol/mol) at the time of recruitment (n = 833) from general practitioners (n = 108) were included. Outcome measures included subjective shared decision making (SDM-Q-9; scale from 0 to 45 (high)) and patient-centeredness (PACIC-D; scale from 1 to 5 (high)) as secondary outcomes. Data collection was performed before intervention (baseline, T0), at 6 months (T1), at 12 months (T2), at 18 months (T3), and at 24 months (T4) after baseline.
Subjective shared decision making decreased in both groups during the course of the study (intervention group: -3.17 between T0 and T4 (95% CI: -4.66, -1.69; p < 0.0001) control group: -2.80 (95% CI: -4.30, -1.30; p = 0.0003)). There were no significant differences between the two groups (-0.37; 95% CI: -2.20, 1.45; p = 0.6847). The intervention's impact on patient-centeredness was minor. Values increased in both groups, but the increase was not statistically significant, nor was the difference between the groups.
The intervention did not increase patient perceived subjective shared decision making and patient-centeredness in the intervention group as compared to the control group. Effects in both groups might be partially attributed to the Hawthorne-effect. Future trials should focus on patient-based intervention elements to investigate effects on shared decision making and patient-centeredness.
The trial was registered on March 10, 2011 at ISRCTN registry under the reference ISRCTN70713571 .
我们研究了对全科医生进行教育干预是否会增加治疗控制不佳的 2 型糖尿病患者的以患者为中心和共同决策感知。
我们在德国初级保健中进行了一项群组随机对照试验。招募时患有 2 型糖尿病的患者(定义为 HbA1c 水平≥8.0%(64mmol/mol))(n=833)来自全科医生(n=108)。主要结局包括主观共同决策(SDM-Q-9;0 至 45 分(高分)的评分)和以患者为中心(PACIC-D;1 至 5 分(高分)的评分)。数据采集在干预前(基线,T0)、6 个月(T1)、12 个月(T2)、18 个月(T3)和 24 个月(T4)进行。
在研究过程中,两组的主观共同决策均下降(干预组:T0 至 T4 期间下降 3.17 分(95%CI:-4.66,-1.69;p<0.0001),对照组:-2.80 分(95%CI:-4.30,-1.30;p=0.0003))。两组之间无显著差异(-0.37;95%CI:-2.20,1.45;p=0.6847)。该干预对以患者为中心的影响较小。两组的数值均增加,但增加不具有统计学意义,组间差异也无统计学意义。
与对照组相比,该干预并未增加干预组患者对主观共同决策和以患者为中心的感知。两组的效果部分可能归因于霍桑效应。未来的试验应侧重于以患者为基础的干预因素,以研究对共同决策和以患者为中心的影响。
该试验于 2011 年 3 月 10 日在 ISRCTN 注册处注册,注册号为 ISRCTN70713571。